Design and Synthesis of a PhotocleaVable Fluorescent Nucleotide
(866 mg; 3.66 mmol). The reaction mixture was stirred at room
temperature for 22 h, and then most solvent was removed under
vacuum. Diethyl ether (200 mL) and saturated aqueous NaHCO3
(50 mL) were added. The organic layer was separated, washed with
saturated aqueous NaCl, and dried over anhydrous Na2SO4. After
evaporation of the solvent, the residue was purified by flash column
chromatography over silica gel using ethyl acetate-hexane (1:3)
as the eluent to afford 3 as white solid (1.98 g; 90% yield): 1H
NMR (400 MHz, CD3OD) δ 7.43 (s, 1H), 6.63 (dd, J ) 6.0, 8.2
Hz, 1H), 5.41 (m, 1H), 4.33-4.36 (m, 2H), 4.23 (m, 1H), 4.09 (s,
3H), 2.78-2.94 (m, 2H), 2.57-2.70 (m, 2H), 2.50-2.57 (ddd, J
) 2.3, 6.0, 14.2 Hz, 1H), 1.17-1.24 (m, 18H); 13C NMR (100
MHz, CD3OD) δ 178.3, 177.8, 177.5, 164.3, 153.3, 152.8, 128.6,
105.2, 85.3, 83.3, 75.8, 65.0, 54.4, 51.8, 38.2, 36.8, 35.2, 35.1, 19.9,
19.3-19.5 (four peaks); HRMS (FAB+) calcd for C24H34O7N4I
(M + H+) 617.1472, found 617.1464.
2-Amino-6-methoxy-7-iodo-9-(â-D-2′-deoxyribofuranosyl)-7-
deazapurine (4). Compound 3 (1.98 g; 3.21 mmol) was dissolved
in 0.5 M methanolic CH3ONa (50 mL) and stirred at 65 °C for 12
h. Saturated aqueous NaHCO3 (20 mL) was added, and the mixture
was stirred for 10 min. Then most of methanol was evaporated,
and the residue was extracted by ethyl acetate (150 mL). The
organic layer was washed with saturated aqueous NaHCO3 and
NaCl, respectively, and dried over anhydrous Na2SO4. After
evaporation of the solvent, the residue was purified by flash column
chromatography over silica gel using CH3OH-CH2Cl2 (1:30-15)
as the eluent to afford 4 as a white solid (1.23 g; 94% yield): 1H
NMR (400 MHz, CD3OD) δ 7.17 (s, 1H), 6.36 (dd, J ) 6.0, 8.4
Hz, 1H), 4.47 (m, 1H), 3.99 (s, 3H), 3.96 (m, 1H), 3.77 (dd, J )
3.4, 12.0 Hz, 1H), 3.70 (dd, J ) 3.7, 12.0 Hz, 1H), 2.55-2.64
(ddd, J ) 6.0, 8.4, 13.4 Hz, 1H), 2.20-2.26 (ddd, J ) 2.4, 5.9,
13.4 Hz, 1H); 13C NMR (100 MHz, CD3OD) δ 164.7, 160.6, 154.3,
126.5, 101.6, 88.7, 86.0, 73.0, 63.7, 53.7, 51.3, 41.1; HRMS
(FAB+) calcd for C12H16O4N4I (M + H+) 407.0216, found
407.0213.
2-Amino-6-methoxy-7-iodo-9-[â-D-5′-O-(tert-butyldimethyl-
silyl)-2′-deoxyribofuranosyl]-7-deazapurine (5). To a stirred
solution of 4 (1.23 g; 3.02 mmol) and imidazole (494 mg; 7.24
mmol) in anhydrous DMF (15 mL) was added tert-butyldimethyl-
silyl chloride (TBDMSCl) (545 mg; 3.51 mmol). The reaction
mixture was stirred at room temperature for 20 h. Then most solvent
was removed under vacuum, and the residue was purified by flash
column chromatography over silica gel using ethyl acetate-hexane
(1:2∼0.5) as the eluent to afford 5 as a white foam (1.38 g; 88%
yield): 1H NMR (400 MHz, CD3OD) δ 7.23 (s, 1H), 6.49 (dd, J
) 6.1, 7.7 Hz, 1H), 4.46 (m, 1H), 3.99 (s, 3H), 3.94 (m, 1H), 3.79-
3.87 (m, 2H), 2.36-2.44 (ddd, J ) 5.8, 7.7, 13.3 Hz, 1H), 2.24-
2.31 (ddd, J ) 3.1, 6.0, 13.3 Hz, 1H), 0.96 (s, 9H), 0.14 (s, 3H),
0.13 (s, 3H); 13C NMR (100 MHz, CD3OD) δ 164.6, 160.7, 154.7,
125.1, 101.0, 88.2, 84.2, 72.7, 64.7, 53.7, 51.7, 41.9, 26.7, 19.4,
-5.0, -5.1; HRMS (FAB+) calcd for C18H30O4N4SiI (M + H+)
521.1081, found 521.1068.
2-Amino-6-methoxy-7-iodo-9-[â-D-3′-O-allyl-5′-O-(tert-butyl-
dimethylsilyl)-2′-deoxyribofuranosyl]-7-deazapurine (6). To a
stirred solution of 5 (1.38 g; 2.66 mmol) in CH2Cl2 (80 mL) were
added tetrabutylammonium bromide (TBAB) (437 mg; 1.33 mmol),
allyl bromide (1.85 mL, 21.4 mmol), and 40% aqueous NaOH
solution (40 mL). The reaction mixture was stirred at room
temperature for 1 h. Ethyl acetate (200 mL) was added, and the
organic layer was separated. The aqueous layer was extracted with
ethyl acetate (2 × 50 mL). The combined organic layer was washed
with saturated aqueous NaHCO3 and NaCl, respectively, and dried
over anhydrous Na2SO4. After evaporation of the solvent, the
residue was purified by flash column chromatography over silica
gel using ethyl acetate-hexane (1:3) as the eluent to afford 6 as a
white solid (1.37 g; 92% yield): 1H NMR (400 MHz, CD3OD) δ
7.20 (s, 1H), 6.43 (dd, J ) 6.2, 7.9 Hz, 1H), 5.89-5.99 (m, 1H),
5.29-5.35 (dm, J ) 17.3 Hz, 1H), 5.16-5.21 (dm, J ) 10.5 Hz,
1H), 4.24 (m, 1H), 4.01-4.11 (m, 3H), 3.99 (s, 3H), 3.76-3.84
(m, 2H), 2.32-2.44 (m, 2H), 0.95 (s, 9H), 0.14 (s, 3H), 0.13 (s,
3H); 13C NMR (100 MHz, CDCl3) δ 163.3, 158.6, 153.6, 134.1,
123.7, 116.9, 100.6, 84.4, 83.0, 79.1, 70.0, 63.6, 53.3, 51.1, 38.1,
26.1, 18.5, -5.1, -5.3; HRMS (FAB+) calcd for C21H34O4N4SiI
(M + H+) 561.1394, found 561.1390.
2-Amino-6-methoxy-7-{3-[(trifluoroacetyl)amino]prop-1-
ynyl]-9-[â-D-3′-O-allyl-5′-O-(tert-butyldimethylsilyl)-2′-deoxyribo-
furanosyl}-7-deazapurine (7). To a stirred solution of 6 (1.37 g;
2.45 mmol) in anhydrous DMF (11 mL) were added tetrakis-
(triphenylphosphine)palladium(0) (286 mg; 0.245 mmol) and CuI
(101 mg; 0.532 mmol). The solution was stirred at room temperature
for 10 min. Then N-propargyltrifluoroacetamide (1.12 g; 7.43 mmol)
and triethylamine (0.68 mL; 4.90 mmol) were added. The reaction
was stirred at room temperature for 13 h with exclusion of air and
light. Most DMF was removed under vacuum, and the residue was
dissolved in ethyl acetate (100 mL). The solution was washed with
saturated aqueous NaHCO3 and NaCl, respectively, and dried over
anhydrous Na2SO4. After evaporation of the solvent, the residue
was purified by flash column chromatography over silica gel using
ethyl acetate-hexane (1:3-1.5) and CH3OH-CH2Cl2 (1:30),
respectively, as the eluent to afford 7 as yellow solid (1.34 g; 94%
yield): 1H NMR (400 MHz, CD3OD) δ 7.34 (s, 1H), 6.42 (dd, J
) 6.2, 7.7 Hz, 1H), 5.88-5.99 (m, 1H), 5.28-5.35 (dm, J ) 17.3
Hz, 1H), 5.16-5.21 (dm, J ) 10.5 Hz, 1H), 4.29 (s, 2H), 4.24 (m,
1H), 4.00-4.09 (m, 3H), 3.98 (s, 3H), 3.76-3.84 (m, 2H), 2.32-
2.45 (m, 2H), 0.94 (s, 9H), 0.12 (s, 3H), 0.11 (s, 3H); 13C NMR
(100 MHz, CD3OD) δ 165.0, 161.2, 158.1 (q, J ) 36 Hz), 154.2,
135.6, 125.0, 117.2 (q, J ) 284 Hz), 117.0, 99.2, 97.3, 86.0, 84.6,
84.5, 80.3, 78.0, 71.0, 64.8, 53.8, 39.0, 30.9, 26.5, 19.3, -5.1, -5.2;
HRMS (FAB+) calcd for C26H37O5N5F3Si (M + H+) 584.2516,
found 584.2491.
3′-O-Allyl-7-{3-[(trifluoroacetyl)amino]prop-1-ynyl}-7-deaza-
2′-deoxyguanosine (8). To a stirred solution of 7 (1.34 g; 2.30
mmol) in anhydrous CH3CN (86 mL) were added NaI (363 mg;
2.42 mmol) and chlorotrimethylsilane (TMSCl) (0.306 mL; 2.42
mmol). The reaction was stirred at room temperature for 1 h and
then at 50 °C for 12 h. The solvent was evaporated, and the residue
was dissolved in anhydrous THF (76 mL). Tetrabutylammonium
fluoride (TBAF) (1 M) in THF solution (4.80 mL; 4.80 mmol) was
added, and the reaction was stirred at room temperature for 1 h.
The solvent was evaporated, and the residue was dissolved in ethyl
acetate (150 mL). The solution was washed with saturated aqueous
NaCl and dried over anhydrous Na2SO4. After evaporation of the
solvent, the residue was purified by flash column chromatography
over silica gel using CH3OH-ethyl acetate (1:30) as the eluent to
afford 8 as yellow solid (356 mg; 34% yield): 1H NMR (400 MHz,
CD3OD) δ 7.21 (s, 1H), 6.30 (dd, J ) 6.0, 8.4 Hz, 1H), 5.88-5.99
(m, 1H), 5.28-5.35 (dm, J ) 17.3 Hz, 1H), 5.15-5.20 (dm, J )
10.5 Hz, 1H), 4.29 (s, 2H), 4.23 (m, 1H), 4.00-4.10 (m, 3H), 3.65-
3.75 (m, 2H), 2.41-2.49 (ddd, J ) 5.8, 8.4, 13.6 Hz, 1H), 2.34-
2.40 (ddd, J ) 2.3, 6.0, 13.6 Hz, 1H); 13C NMR (100 MHz,
CD3OD) δ 160.9, 158.0 (q, J ) 36 Hz), 154.1, 151.8, 135.6, 124.4,
117.2 (q, J ) 284 Hz), 117.0, 101.4, 99.7, 86.4, 85.5, 84.8, 80.7,
78.0, 71.0, 63.7, 38.5, 31.2; HRMS (FAB+) calcd for C19H21O5N5F3
(M + H+) 456.1495, found 456.1493.
3′-O-Allyl-7-(3-aminoprop-1-ynyl)-7-deaza-2′-deoxyguanosine-
5′-triphosphate (9). The procedure is the same as that of preparing
3′-O-allyl-5-(3-aminoprop-1-ynyl)-2′-deoxyuridine-5′-triphos-
phate in ref 2 to yield 9 as a colorless syrup: 1H NMR (300 MHz,
D2O) δ 7.56 (s, 1H), 6.37 (t, J ) 7.3 Hz, 1H), 5.89-6.02 (m, 1H),
5.31-5.39 (dm, J ) 17.3 Hz, 1H), 5.21-5.28 (dm, J ) 10.5 Hz,
1H), 4.49 (s, 2H), 4.32 (m, 1H), 4.06-4.18 (m, 3H), 3.92-3.99
(m, 2H), 2.44-2.60 (m, 2H);31P NMR (121.4 MHz, D2O) δ -6.1
(d, J ) 20.8 Hz, 1P), -10.8 (d, J ) 18.9 Hz, 1P), -21.9 (t, J )
19.8 Hz, 1P).
3′-O-Allyl-dGTP-PC-Bodipy-FL-510 (10). PC-Bodipy-FL-510
NHS ester (prepared by the same procedure as in ref 9) (7.2 mg,
12 µmol) in 300 µL of acetonitrile was added to a solution of 9 (2
mg, 3.4 µmol) in 300 µL of Na2CO3-NaHCO3 aqueous buffer (0.1
J. Org. Chem, Vol. 71, No. 8, 2006 3251